Cargando…

Immunogenicity of COVID-19 Vaccinations in Hematological Patients: 6-Month Follow-Up and Evaluation of a 3rd Vaccination

SIMPLE SUMMARY: Here we confirm lower humoral and cellular responses in hematological patients compared with controls and highlight the response in risk-groups such as CAR-T-cell recipients. The main risk factor for a poor humoral response was anti-CD20 therapy. CD19(+) B-cell and CD4(+) T-cell leve...

Descripción completa

Detalles Bibliográficos
Autores principales:	Schubert, Lorenz, Koblischke, Maximilian, Schneider, Lisa, Porpaczy, Edit, Winkler, Florian, Jaeger, Ulrich, Blüml, Stephan, Haslacher, Helmuth, Burgmann, Heinz, Aberle, Judith H., Winkler, Stefan, Tobudic, Selma
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2022
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9032993/ https://www.ncbi.nlm.nih.gov/pubmed/35454867 http://dx.doi.org/10.3390/cancers14081962

Ejemplares similares

Immune Response after mRNA COVID-19 Vaccination in Lung Transplant Recipients: A 6-Month Follow-Up
por: Tobudic, Selma, et al.
Publicado: (2022)

SARS-CoV-2 Vaccine Response in Patients With Autoimmune Hepatitis
por: Schneider, Lisa, et al.
Publicado: (2022)

The accelerated waning of immunity and reduced effect of booster in patients treated with bDMARD and tsDMARD after SARS-CoV-2 mRNA vaccination
por: Tobudic, Selma, et al.
Publicado: (2023)

Reactogenicity and immunogenicity of the second COVID-19 vaccination in patients with inborn errors of immunity or mannan-binding lectin deficiency
por: Göschl, Lisa, et al.
Publicado: (2022)

B Cell Depletion and SARS‐CoV‐2 Vaccine Responses in Neuroimmunologic Patients
por: Kornek, Barbara, et al.
Publicado: (2022)

Renal Abscess: A Rare Complication of Paratyphoid Fever in an Immunocompetent Traveler from Southeast Asia
por: Schubert, Lorenz, et al.
Publicado: (2021)

Randomized, Single Blind, Controlled Trial to Evaluate the Prime-Boost Strategy for Pneumococcal Vaccination in Renal Transplant Recipients
por: Tobudic, Selma, et al.
Publicado: (2012)

Human Borrelia miyamotoi Infection, Austria
por: Tobudic, Selma, et al.
Publicado: (2020)

Prevalence and Outcome of Secondary Hemophagocytic Lymphohistiocytosis Among SIRS Patients: Results from a Prospective Cohort Study
por: Gualdoni, Guido A., et al.
Publicado: (2019)

Low immunogenicity of whole virion, verocell-derived, inactivated, pandemic influenza H1N1 vaccine in HIV-infected patients
por: Lagler, H, et al.
Publicado: (2010)

Immunogenicity and Tolerability after Two Doses of Non-Adjuvanted, Whole-Virion Pandemic Influenza A (H1N1) Vaccine in HIV-Infected Individuals
por: Lagler, Heimo, et al.
Publicado: (2012)

Heterologous vector versus homologous mRNA COVID-19 booster vaccination in non-seroconverted immunosuppressed patients: a randomized controlled trial
por: Mrak, Daniel, et al.
Publicado: (2022)

Low nasal carriage of drug-resistant bacteria among medical students in Vienna
por: Gualdoni, Guido A., et al.
Publicado: (2012)

SARS-CoV-2 seroprevalence in oncology healthcare professionals and patients with cancer at a tertiary care centre during the COVID-19 pandemic
por: Fuereder, Thorsten, et al.
Publicado: (2020)

Protein structure shapes immunodominance in the CD4 T cell response to yellow fever vaccination
por: Koblischke, Maximilian, et al.
Publicado: (2017)

Humoral Immune Response Following SARS-CoV-2 mRNA Vaccination and Infection in Pediatric-Onset Multiple Sclerosis
por: Breu, Markus, et al.
Publicado: (2023)

Course of Fecal Calprotectin after mRNA SARS-CoV-2 Vaccination in Patients with Inflammatory Bowel Diseases
por: Pokryszka, Jagoda, et al.
Publicado: (2022)

Enhanced SARS-CoV-2 breakthrough infections in patients with hematologic and solid cancers due to Omicron
por: Mair, Maximilian J., et al.
Publicado: (2022)

Third dose of SARS-CoV-2 vaccination in hemato-oncological patients and health care workers: immune responses and adverse events – a retrospective cohort study
por: Mair, Maximilian J., et al.
Publicado: (2022)

Early treatment response to piperacillin/tazobactam in patients with bloodstream infections caused by non-ESBL ampicillin/sulbactam-resistant Escherichia coli: a binational cohort study
por: Tobudic, Selma, et al.
Publicado: (2023)

Lymphoma in Danon disease with chronic rhabdomyolysis treated with EPOCH-R: A case report
por: Porpaczy, Edit, et al.
Publicado: (2016)

Evaluation of the Septifast M(Grade) Test on Standard Care Wards—A Cohort Study
por: Ratzinger, Franz, et al.
Publicado: (2016)

A Longitudinal Seroprevalence Study Evaluating Infection Control and Prevention Strategies at a Large Tertiary Care Center with Low COVID-19 Incidence
por: Schubert, Lorenz, et al.
Publicado: (2021)

Utility of Sepsis Biomarkers and the Infection Probability Score to Discriminate Sepsis and Systemic Inflammatory Response Syndrome in Standard Care Patients
por: Ratzinger, Franz, et al.
Publicado: (2013)

Machine learning for fast identification of bacteraemia in SIRS patients treated on standard care wards: a cohort study
por: Ratzinger, Franz, et al.
Publicado: (2018)

Weak immunogenicity of SARS-CoV-2 vaccine in patients with hematologic malignancies
por: Malard, Florent, et al.
Publicado: (2021)

Immunogenicity profile after COVID-19 vaccination in patients with onco-hematological diseases
por: de Almeida, João Bosco, et al.
Publicado: (2023)

Accelerated waning of immune responses to a third COVID-19 vaccination in patients with immune-mediated inflammatory diseases
por: Mrak, Daniel, et al.
Publicado: (2023)

Structural Influence on the Dominance of Virus-Specific CD4 T Cell Epitopes in Zika Virus Infection
por: Koblischke, Maximilian, et al.
Publicado: (2018)

Corrigendum: Structural Influence on the Dominance of Virus-Specific CD4 T Cell Epitopes in Zika Virus Infection
por: Koblischke, Maximilian, et al.
Publicado: (2018)

Incidence and characteristics of invasive fungal diseases in allogeneic hematopoietic stem cell transplant recipients: a retrospective cohort study
por: Harrison, Nicole, et al.
Publicado: (2015)

Compatibility of aztreonam in four commercial peritoneal dialysis fluids
por: Tobudic, Selma, et al.
Publicado: (2020)

Bone turnover markers can predict healing time in medication-related osteonecrosis of the jaw
por: Schubert, Lorenz, et al.
Publicado: (2021)

P1557: A STUDY ON THE IMMUNOGENICITY OF COVID-19 VACCINE IN PATIENTS WITH HEMATOLOGIC MALIGNANCY
por: Mesina, Flordeluna, et al.
Publicado: (2023)

Immunogenicity of COVID-19 vaccines in patients with hematologic malignancies: a systematic review and meta-analysis
por: Teh, Joanne S. K., et al.
Publicado: (2022)

Effectiveness, immunogenicity, and safety of COVID-19 vaccines for individuals with hematological malignancies: a systematic review
por: Piechotta, Vanessa, et al.
Publicado: (2022)

25(OH)D and 1,25(OH)D vitamin D fails to predict sepsis and mortality in a prospective cohort study
por: Ratzinger, Franz, et al.
Publicado: (2017)

Breakthrough infections with SARS-CoV-2 omicron efficiently boost antibodies from previous BNT162b2 vaccinations
por: Perkmann, Thomas, et al.
Publicado: (2023)

Letermovir for the compassionate therapeutic use of cytomegalovirus infection
por: Schubert, Lorenz, et al.
Publicado: (2020)

SARS-CoV-2 vaccine safety and immunogenicity in patients with hematologic malignancies, transplantation, and cellular therapies
por: Ni, Bin, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_tedcqsjbl8081v0ve19kkl3770